期刊文献+

急性白血病药物治疗后红细胞生成素的改变 被引量:2

Erythropoietin Variation in Acute Leukemia Before and After Intensive Cytostatic Draugs
下载PDF
导出
摘要 对43例急性白血病患者细胞毒药物治疗前后的红细胞生成素(EPO)进行观察,并与正常人组、其他贫血组进行对照。发现急性白血病化疗前EPO水平高于正常人(P<0.01),但低于同等程度贫血的其他疾病组(P<0.01)。化疗后在Hb无明显改变的情况下,EPO水平急剧增高,显著高于化疗前水平(P<0.01)。骨髓抑制严重者EPO上升幅度大。细胞毒药物引起EPO水平异常增高的原因尚不清楚,骨髓受抑制EPO消耗减少,细胞毒药物通过某些机制使EPO活性增加或刺激EPO合成,为可能的因素。 Serum erythropoietin(EPO)was measured in 43 patients with acute leukemia before and after intensive chemotherapy. The EPO levels in acute leukemia was higher than that in the control normal population(P<0.01)and lower than th at in other diseased patients with anaemia(P<o.01)before chemotherapy. In all patients with leakemia EPO markedly increased after initiation of treatment,although the hemoglobin concentration remained at stable values. Subsequently the EPO returned to baseline levels after 3 weeks even in patients who were anaemic at the ture. The explanation for this inappropriate increase in EPO is not clear. The possible explanation for elevated levels is that they are caused by decreased consumption from suppression of the marrow,or by cytostatic treatment which stimulated EPO synthesis via a hitherto unknow mechanism.
出处 《上海第二医科大学学报》 CSCD 1995年第2期110-113,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 急性 白血病 药物疗法 红细胞生成素 erythropoietin acute leakemia cytostatic drugs
  • 相关文献

同被引文献2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部